Patient Registry of Intrathecal Pain Management in Europe for Prialt (Ziconotide Intrathecal Infusion) and Alternative Drugs for the Management of Severe, Chronic Pain. (PRIME)

Trial Profile

Patient Registry of Intrathecal Pain Management in Europe for Prialt (Ziconotide Intrathecal Infusion) and Alternative Drugs for the Management of Severe, Chronic Pain. (PRIME)

Completed
Phase of Trial: Phase IV

Latest Information Update: 16 Oct 2014

At a glance

  • Drugs Analgesics; Ziconotide
  • Indications Pain
  • Focus Therapeutic Use
  • Acronyms PRIME
  • Sponsors Eisai Inc
  • Most Recent Events

    • 16 Oct 2014 New source identified and integrated (ClinicalTrials.gov record:NCT02268812)
    • 02 Sep 2010 Sixty-seven patients have been enrolled, according to information presented at the 13th World Congress of Pain.
    • 16 Aug 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top